474 related articles for article (PubMed ID: 32796572)
1. The Multifunctionality of CD36 in Diabetes Mellitus and Its Complications-Update in Pathogenesis, Treatment and Monitoring.
Puchałowicz K; Rać ME
Cells; 2020 Aug; 9(8):. PubMed ID: 32796572
[TBL] [Abstract][Full Text] [Related]
2. The Role of CD36 in Type 2 Diabetes Mellitus: β-Cell Dysfunction and Beyond.
Moon JS; Karunakaran U; Suma E; Chung SM; Won KC
Diabetes Metab J; 2020 Apr; 44(2):222-233. PubMed ID: 32347024
[TBL] [Abstract][Full Text] [Related]
3. CD36 Signal Transduction in Metabolic Diseases: Novel Insights and Therapeutic Targeting.
Karunakaran U; Elumalai S; Moon JS; Won KC
Cells; 2021 Jul; 10(7):. PubMed ID: 34360006
[TBL] [Abstract][Full Text] [Related]
4. Advanced Oxidation Protein Products Promote Lipotoxicity and Tubulointerstitial Fibrosis
Li X; Zhang T; Geng J; Wu Z; Xu L; Liu J; Tian J; Zhou Z; Nie J; Bai X
Antioxid Redox Signal; 2019 Sep; 31(7):521-538. PubMed ID: 31084358
[No Abstract] [Full Text] [Related]
5. Cluster Differentiating 36 (CD36) Deficiency Attenuates Obesity-Associated Oxidative Stress in the Heart.
Gharib M; Tao H; Fungwe TV; Hajri T
PLoS One; 2016; 11(5):e0155611. PubMed ID: 27195707
[TBL] [Abstract][Full Text] [Related]
6. Dynamic role of the transmembrane glycoprotein CD36 (SR-B2) in cellular fatty acid uptake and utilization.
Glatz JFC; Luiken JJFP
J Lipid Res; 2018 Jul; 59(7):1084-1093. PubMed ID: 29627764
[TBL] [Abstract][Full Text] [Related]
7. Role of the Scavenger Receptor CD36 in Accelerated Diabetic Atherosclerosis.
Navas-Madroñal M; Castelblanco E; Camacho M; Consegal M; Ramirez-Morros A; Sarrias MR; Perez P; Alonso N; Galán M; Mauricio D
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33028031
[TBL] [Abstract][Full Text] [Related]
8. The role and regulation of CD36 for fatty acid imaging of the heart: implications in diabetes mellitus and chronic kidney disease.
Aras O; Dilsizian V
J Nucl Cardiol; 2007; 14(3 Suppl):S110-7. PubMed ID: 17556178
[No Abstract] [Full Text] [Related]
9. Omega-3 fatty acids attenuate constitutive and insulin-induced CD36 expression through a suppression of PPAR α/γ activity in microvascular endothelial cells.
Madonna R; Salerni S; Schiavone D; Glatz JF; Geng YJ; De Caterina R
Thromb Haemost; 2011 Sep; 106(3):500-10. PubMed ID: 21727988
[TBL] [Abstract][Full Text] [Related]
10. Pathogenic role of scavenger receptor CD36 in the metabolic syndrome and diabetes.
Kennedy DJ; Kashyap SR
Metab Syndr Relat Disord; 2011 Aug; 9(4):239-45. PubMed ID: 21428745
[TBL] [Abstract][Full Text] [Related]
11. The impact of FOXO-1 to cardiac pathology in diabetes mellitus and diabetes-related metabolic abnormalities.
Chistiakov DA; Orekhov AN; Bobryshev YV
Int J Cardiol; 2017 Oct; 245():236-244. PubMed ID: 28781146
[TBL] [Abstract][Full Text] [Related]
12. Metformin prevents glucotoxicity by alleviating oxidative and ER stress-induced CD36 expression in pancreatic beta cells.
Moon JS; Karunakaran U; Elumalai S; Lee IK; Lee HW; Kim YW; Won KC
J Diabetes Complications; 2017 Jan; 31(1):21-30. PubMed ID: 27662780
[TBL] [Abstract][Full Text] [Related]
13. Long-chain fatty acid activates hepatocytes through CD36 mediated oxidative stress.
Liu J; Yang P; Zuo G; He S; Tan W; Zhang X; Su C; Zhao L; Wei L; Chen Y; Ruan X; Chen Y
Lipids Health Dis; 2018 Jul; 17(1):153. PubMed ID: 30016988
[TBL] [Abstract][Full Text] [Related]
14. Rac1-NADPH oxidase signaling promotes CD36 activation under glucotoxic conditions in pancreatic beta cells.
Elumalai S; Karunakaran U; Lee IK; Moon JS; Won KC
Redox Biol; 2017 Apr; 11():126-134. PubMed ID: 27912197
[TBL] [Abstract][Full Text] [Related]
15. CD36 mediates lipid accumulation in pancreatic beta cells under the duress of glucolipotoxic conditions: Novel roles of lysine deacetylases.
Khan S; Kowluru A
Biochem Biophys Res Commun; 2018 Jan; 495(3):2221-2226. PubMed ID: 29274335
[TBL] [Abstract][Full Text] [Related]
16. Muscle-specific overexpression of CD36 reverses the insulin resistance and diabetes of MKR mice.
Héron-Milhavet L; Haluzik M; Yakar S; Gavrilova O; Pack S; Jou WC; Ibrahimi A; Kim H; Hunt D; Yau D; Asghar Z; Joseph J; Wheeler MB; Abumrad NA; LeRoith D
Endocrinology; 2004 Oct; 145(10):4667-76. PubMed ID: 15231693
[TBL] [Abstract][Full Text] [Related]
17. Fatty acid translocase (FAT/CD36) is localized on insulin-containing granules in human pancreatic beta-cells and mediates fatty acid effects on insulin secretion.
Noushmehr H; D'Amico E; Farilla L; Hui H; Wawrowsky KA; Mlynarski W; Doria A; Abumrad NA; Perfetti R
Diabetes; 2005 Feb; 54(2):472-81. PubMed ID: 15677505
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanism of lipid-induced cardiac insulin resistance and contractile dysfunction.
Liu Y; Neumann D; Glatz JFC; Luiken JJFP
Prostaglandins Leukot Essent Fatty Acids; 2018 Sep; 136():131-141. PubMed ID: 27372802
[TBL] [Abstract][Full Text] [Related]
19. CD36 signaling in vascular redox stress.
Yang M; Silverstein RL
Free Radic Biol Med; 2019 May; 136():159-171. PubMed ID: 30825500
[TBL] [Abstract][Full Text] [Related]
20. CD36 as a gatekeeper of myocardial lipid metabolism and therapeutic target for metabolic disease.
Glatz JFC; Heather LC; Luiken JJFP
Physiol Rev; 2024 Apr; 104(2):727-764. PubMed ID: 37882731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
